Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

A Comparison between Extract Products of Magnolia officinalis on Memory Impairment and Amyloidogenesis in a Transgenic Mouse Model of Alzheimer's Disease

  • Received : 2012.04.02
  • Accepted : 2012.05.04
  • Published : 2012.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

The components of Magnolia officinalis have well known to act anti-inflammatory, anti-oxidative and neuroprotective activities. These efficacies have been sold many products as nutritional supplement extracted from bark of Magnolia officinalis. Thus, to assess and compare neuroprotective effect in the nutritional supplement (Magnolia $Extract^{TM}$, Health Freedom Nutrition LLC, USA) and our ethanol extract of Magnolia officinalis (BioLand LTD, Korea), we investigated memorial improving and anti-Alzheimer's disease effects of extract products of Magnolia officinalis in a transgenic AD mice model. Oral pretreatment of two extract products of Magnolia officinalis (10 mg/kg/day in 0.05% ethanol) into drinking water for 3 months ameliorated memorial dysfunction and prevented $A{\beta}$ accumulation in the brain of Tg2576 mice. In addition, extract products of Magnolia officinalis also decreased expression of ${\beta}$-site APP cleaving enzyme 1 (BACE1), amyloid precursor protein (APP) and its product, C99. Although both two extract products of Magnolia officinalis could show preventive effect of memorial dysfunction and $A{\beta}$ accumulation, our ethanol extract of Magnolia officinalis (BioLand LTD, Korea) could be more effective than Magnolia $Extract^{TM}$ (Health Freedom Nutrition LLC, USA). Therefore, our results showed that extract products of Magnolia officinalis were effective for prevention and treatment of AD through memorial improving and anti-amyloidogenic effects via down-regulating ${\beta}$-secretase activity, and neuroprotective efficacy of Magnolia extracts could be differed by cultivating area and manufacturing methods.

Keywords

References

  1. Blennow, K., de Leon, M. J. and Zetterberg, H. (2006) Alzheimer's disease. Lancet 368, 387-403. https://doi.org/10.1016/S0140-6736(06)69113-7
  2. Castellani, R. J., Zhu, X., Lee, H. G., Moreira, P. I., Perry, G. and Smith, M. A. (2007) Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees? Expert Rev. Neurother. 7, 473-485. https://doi.org/10.1586/14737175.7.5.473
  3. Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V., Hyman, B. T., Younkin, S. G. and Hsiao, K. K. (1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2, 271-276. https://doi.org/10.1038/6374
  4. Chen, C. L., Chang, P. L., Lee, S. S., Peng, F. C., Kuo, C. H. and Chang, H. T. (2007) Analysis of magnolol and honokiol in biological fluids by capillary zone electrophoresis. J. Chromatogr. A 1142, 240-244. https://doi.org/10.1016/j.chroma.2006.12.099
  5. Choi, D. Y., Lee, J. W., Lin, G., Lee, Y. K., Lee, Y. H., Choi, I. S., Han, S.B., Jung, J. K., Kim, Y. H., Kim, K. H., Oh, K. W., Hong, J. T. and Lee, M. S. (2012a) Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-${\kappa}B$ signaling pathway. Neurochem. Int. 60, 68-77. https://doi.org/10.1016/j.neuint.2011.11.005
  6. Choi, D. Y., Lee, J. W., Peng, J., Lee, Y. J., Han, J. Y., Lee, Y. H., Choi, I. S., Han, S. B., Jung, J. K., Lee, W. S., Lee, S. H., Kwon, B. M., Oh, K. W. and Hong, J. T. (2012b) Obovatol improves cognitive functions in animal models for Alzheimer's disease. J. Neurochem. 120, 1048-1059.
  7. Choi, I. S., Lee, Y. J., Choi, D. Y., Lee, Y. K., Lee, Y. H., Kim, K. H., Kim, Y. H., Jeon, Y. H., Kim, E. H., Han, S. B., Jung, J. K., Yun, Y. P., Oh, K. W., Hwang, D. Y. and Hong, J. T. (2011) 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-$\beta$ generation and accumulation in a mouse model of Alzheimer's disease. J. Alzheimers Dis. 27, 127-141.
  8. Choi, J. H., Ha, J., Park, J. H., Lee, J. Y., Lee, Y. S., Park, H. J., Choi, J. W., Masuda, Y., Nakaya, K. and Lee, K. T. (2002) Costunolide triggers apoptosis in human leukemia U937 cells by depleting intracellular thiols. Jpn. J. Cancer Res. 93, 1327-1333. https://doi.org/10.1111/j.1349-7006.2002.tb01241.x
  9. Cole, S. L. and Vassar, R. (2007) The Alzheimer's disease beta-secretase enzyme, BACE1. Mol. Neurodegener. 2, 22. https://doi.org/10.1186/1750-1326-2-22
  10. Cui, H. S., Huang, L. S., Sok, D. E., Shin, J., Kwon, B. M., Youn, U. J. and Bae, K. (2007) Protective action of honokiol, administered orally, against oxidative stress in brain of mice challenged with NMDA. Phytomedicine 14, 696-700. https://doi.org/10.1016/j.phymed.2007.03.005
  11. De Strooper, B. and Annaert, W. (2000) Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci. 113, 1857-1870.
  12. Dikalov, S., Losik, T. and Arbiser, J. L. (2008) Honokiol is a potent scavenger of superoxide and peroxyl radicals. Biochem. Pharmacol. 76, 589-596. https://doi.org/10.1016/j.bcp.2008.06.012
  13. Duff, K. and Suleman, F. (2004). Transgenic mouse models of Alzheimer's disease: how useful have they been for therapeutic development? Brief. Funct. Genomic. Proteomic. 3, 47-59. https://doi.org/10.1093/bfgp/3.1.47
  14. Ferri, C. P., Sousa, R., Albanese, E., Ribeiro, W. S. and Honyashiki, M. (2009) World Alzheimer Report 2009 - Executive Summary. (M. Prince and J. Jackson, Eds.), pp. 1-22. Alzheimer's Disease International, London.
  15. Fujita, S. and Taira, J. (1994) Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102. Free Radic. Biol. Med. 17, 273-277. https://doi.org/10.1016/0891-5849(94)90083-3
  16. Golde, T. E., Dickson, D. and Hutton, M. (2006) Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease. Curr. Alzheimer Res. 3, 421-430. https://doi.org/10.2174/156720506779025189
  17. Hoi, C. P., Ho, Y. P., Baum, L. and Chow, A. H. (2010) Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells. Phytother. Res. 24, 1538-1542. https://doi.org/10.1002/ptr.3178
  18. Hou, Y. C., Chao, P. D. and Chen, S. Y. (2000) Honokiol and magnolol increased hippocampal acetylcholine release in freely-moving rats. Am. J. Chin. Med. 28, 379-384. https://doi.org/10.1142/S0192415X00000441
  19. Hsiao, K. (1998) Transgenic mice expressing Alzheimer amyloid precursor proteins. Exp. Gerontol. 33, 883-889. https://doi.org/10.1016/S0531-5565(98)00045-X
  20. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. and Cole, G. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102. https://doi.org/10.1126/science.274.5284.99
  21. Ito, K., Iida, T., Ichino, K., Tsunezuka, M., Hattori, M. and Namba, T. (1982) Obovatol and obovatal, novel biphenyl ether lignans from the leaves of Magnolia obovata Thunb. Chem. Pharm. Bull. (Tokyo) 30, 3347-3353. https://doi.org/10.1248/cpb.30.3347
  22. Iwasaki, K., Wang, Q., Seki, H., Satoh, K., Takeda, A., Arai, H. and Sasaki, H. (2000) The effects of the traditional chinese medicine, "Banxia Houpo Tang (Hange-Koboku To)" on the swallowing refl ex in Parkinson's disease. Phytomedicine 7, 259-263. https://doi.org/10.1016/S0944-7113(00)80042-2
  23. Janus, C. and Westaway, D. (2001) Transgenic mouse models of Alzheimer's disease. Physiol. Behav. 73, 873-886. https://doi.org/10.1016/S0031-9384(01)00524-8
  24. Kang, J. S., Lee, K. H., Han, M. H., Lee, H., Ahn, J. M., Han, S. B., Han, G., Lee, K., Park, S. K. and Kim, H. M. (2008) Antiinflammatory activity of methanol extract isolated from stem bark of Magnolia kobus. Phytother. Res. 22, 883-888. https://doi.org/10.1002/ptr.2386
  25. Kong, C. W., Tsai, K., Chin, J. H., Chan, W. L. and Hong, C. Y. (2000) Magnolol attenuates peroxidative damage and improves survival of rats with sepsis. Shock 13, 24-28. https://doi.org/10.1097/00024382-200013010-00005
  26. Kuribara, H., Stavinoha, W. B. and Maruyama, Y. (1998) Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. J. Pharm. Pharmacol. 50, 819-826. https://doi.org/10.1111/j.2042-7158.1998.tb07146.x
  27. Lee, J. W., Lee, Y. K., Lee, B. J., Nam, S. Y., Lee, S. I., Kim, Y. H., Kim, K. H., Oh, K. W. and Hong, J. T. (2010) Inhibitory effect of ethanol extract of Magnolia offi cinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid. Pharmacol. Biochem. Behav. 95, 31-40. https://doi.org/10.1016/j.pbb.2009.12.003
  28. Lee, M., Kwon, B. M., Suk, K., McGeer, E. and McGeer, P. L. (2012a) Effects of obovatol on GSH depleted glia-mediated neurotoxicity and oxidative damage. J. Neuroimmune. Pharmacol. 7, 173-186. https://doi.org/10.1007/s11481-011-9300-9
  29. Lee, Y. J., Choi, D. Y., Choi, I. S., Kim, K. H., Kim, Y. H., Kim, H. M., Lee, K., Cho, W. G., Jung, J. K., Han, S. B., Han, J. Y., Nam, S. Y., Yun, Y. W., Jeong, J. H., Oh, K. W. and Hong, J. T. (2012b) Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinfl ammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models. J. Neuroinfl ammation 9, 35. https://doi.org/10.1186/1742-2094-9-35
  30. Lee, Y. J., Choi, D. Y., Han, S. B., Kim, Y. H., Kim, K. H., Hwang, B. Y., Kang, J. K., Lee, B. J., Oh, K. W. and Hong, J. T. (2012c) Inhibitory Effect of Ethanol Extract of Magnolia offi cinalis on Memory Impairment and Amyloidogenesis in a Transgenic Mouse Model of Alzheimer's Disease via Regulating $\beta$-Secretase Activity. Phytother. Res. [Epub ahead of print]
  31. Lee, Y. J., Choi, D. Y., Lee, Y. K., Lee, Y. M., Han, S. B., Kim, Y. H., Kim, K. H., Nam, S. Y., Lee, B. J., Kang, J. K., Yun, Y. W., Oh, K. W. and Hong, J. T. (2012d) 4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer's disease via regulation of $\beta$-secretase activity. J. Alzheimers Dis. 29, 677-690.
  32. Lee, Y. J., Choi, I. S., Park, M. H., Lee, Y. M., Song, J. K., Kim, Y. H., Kim, K. H., Hwang, D. Y., Jeong, J. H., Yun, Y. P., Oh, K. W., Jung, J. K., Han, S. B. and Hong, J. T. (2011a) 4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway. Free Radic. Biol. Med. 50, 66-77. https://doi.org/10.1016/j.freeradbiomed.2010.10.698
  33. Lee, Y. J., Lee, Y. M., Lee, C. K., Jung, J. K., Han, S. B. and Hong, J. T. (2011b) Therapeutic applications of compounds in the Magnolia family. Pharmacol. Ther. 130, 157-176. https://doi.org/10.1016/j.pharmthera.2011.01.010
  34. Lee, Y. K., Choi, I. S., Ban, J. O., Lee, H. J., Lee, U. S., Han, S. B., Jung, J. K., Kim, Y. H., Kim, K. H., Oh, K. W. and Hong, J. T. (2011c) 4-O-methylhonokiol attenuated $\beta$-amyloid-induced memory impairment through reduction of oxidative damages via inactivation of p38 MAP kinase. J. Nutr. Biochem. 22, 476-486. https://doi.org/10.1016/j.jnutbio.2010.04.002
  35. Lee, Y. K., Yuk, D. Y., Kim, T. I., Kim, Y. H., Kim, K. T., Kim, K. H., Lee, B. J., Nam, S. Y. and Hong, J. T. (2009) Protective effect of the ethanol extract of Magnolia offi cinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity. J. Nat. Med. 63, 274-282. https://doi.org/10.1007/s11418-009-0330-z
  36. Lin, S. P., Tsai, S. Y., Lee Chao, P. D., Chen, Y. C. and Hou, Y. C. (2011) Pharmacokinetics, bioavailability, and tissue distribution of magnolol following single and repeated dosing of magnolol to rats. Planta Med. 77, 1800-1805. https://doi.org/10.1055/s-0030-1271159
  37. Lin, X., Koelsch, G., Wu, S., Downs, D., Dashti, A. and Tang, J. (2000) Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc. Natl. Acad. Sci. USA 97, 1456-1460. https://doi.org/10.1073/pnas.97.4.1456
  38. Lin, Y. R., Chen, H. H., Ko, C. H. and Chan, M. H. (2007) Effects of honokiol and magnolol on acute and infl ammatory pain models in mice. Life Sci. 81, 1071-1078. https://doi.org/10.1016/j.lfs.2007.08.014
  39. Lin, Y. R., Chen, H. H., Ko, C. H. and Chan, M. H. (2006) Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur. J. Pharmacol. 537, 64-69. https://doi.org/10.1016/j.ejphar.2006.03.035
  40. Luo, L., Nong Wang, J., Kong, L. D., Jiang, Q. G. and Tan, R. X. (2000) Antidepressant effects of Banxia Houpu decoction, a traditional Chinese medicinal empirical formula. J. Ethnopharmacol. 73, 277-281. https://doi.org/10.1016/S0378-8741(00)00242-7
  41. Matsui, N., Takahashi, K., Takeichi, M., Kuroshita, T., Noguchi, K., Yamazaki, K., Tagashira, H., Tsutsui, K., Okada, H., Kido, Y., Yasui, Y., Fukuishi, N., Fukuyama, Y. and Akagi. M. (2009) Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice. Brain Res. 1305, 108-117. https://doi.org/10.1016/j.brainres.2009.09.107
  42. Morris, R. (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47-60. https://doi.org/10.1016/0165-0270(84)90007-4
  43. Munroe, M. E., Arbiser, J. L. and Bishop, G. A. (2007) Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J. Immunol. 179, 753-763. https://doi.org/10.4049/jimmunol.179.2.753
  44. Selkoe, D. J. (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447-453. https://doi.org/10.1016/S0962-8924(98)01363-4
  45. Song, W. Z., Cui, J. F. and Zhang, G. D. (1989) Studies on the medicinal plants of Magnoliaceae tu-hou-po of Manglietia. Yao. Xue. Xue. Bao. 24, 295-299.
  46. Tachikawa, E., Takahashi, M. and Kashimoto, T. (2000) Effects of extract and ingredients isolated from Magnolia obovata thunberg on catecholamine secretion from bovine adrenal chromaffin cells. Biochem. Pharmacol. 60, 433-440. https://doi.org/10.1016/S0006-2952(00)00343-9
  47. Tsai, T. H., Chou, C. J. and Chen, C. F. (1996) Pharmacokinetics and brain distribution of magnolol in the rat after intravenous bolus injection. J. Pharm. Pharmacol. 48, 57-59. https://doi.org/10.1111/j.2042-7158.1996.tb05877.x
  48. Watanabe, K., Watanabe, H., Goto, Y., Yamaguchi, M., Yamamoto, N. and Hagino, K. (1983) Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: central depressant effects. Planta Med. 49, 103-108. https://doi.org/10.1055/s-2007-969825
  49. Weeks, B. S. (2009) Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian. Med. Sci. Monit. 15, RA256-262.
  50. Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G. and Ashe, K. H. (2002) The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22, 1858-1867.
  51. Xu, Q., Yi, L. T., Pan, Y., Wang, X., Li, Y. C., Li, J. M., Wang, C. P. and Kong, L. D. (2008) Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Prog. Neuropsychopharmacol. Biol. Psychiatry. 32, 715-725. https://doi.org/10.1016/j.pnpbp.2007.11.020
  52. Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashier, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., Carter, D. B., Tomasselli, A. G., Parodi, L. A., Heinrikson, R. L. and Gurney, M. E. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533-537. https://doi.org/10.1038/990107
  53. Zhou, H. Y., Shin, E. M., Guo, L. Y., Youn, U. J., Bae, K., Kang, S. S., Zou, L. B. and Kim, Y. S. (2008) Anti-infl ammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation. Eur. J. Pharmacol. 586, 340-349. https://doi.org/10.1016/j.ejphar.2008.02.044

Cited by

  1. The treatment of Alzheimer's disease using Chinese Medicinal Plants: From disease models to potential clinical applications vol.152, pp.3, 2014, https://doi.org/10.1016/j.jep.2013.12.053
  2. Effects of ginseol k-g3, an Rg3-enriched fraction, on scopolamine-induced memory impairment and learning deficit in mice vol.38, pp.1, 2014, https://doi.org/10.1016/j.jgr.2013.11.003
  3. Oligonol improves memory and cognition under an amyloid β25-35–induced Alzheimer's mouse model vol.34, pp.7, 2014, https://doi.org/10.1016/j.nutres.2014.06.008
  4. Sample injection strategy to increase throughput in counter-current chromatography: Case study of Honokiol purification vol.1476, 2016, https://doi.org/10.1016/j.chroma.2016.10.040
  5. Modulation of Rat Hepatic CYP1A and 2C Activity by Honokiol and Magnolol: Differential Effects on Phenacetin and Diclofenac Pharmacokinetics In Vivo vol.23, pp.6, 2018, https://doi.org/10.3390/molecules23061470
  6. Pharmacokinetic and Metabolic Profiling of Key Active Components of Dietary Supplement Magnolia officinalis Extract for Prevention against Oral Carcinoma vol.68, pp.24, 2020, https://doi.org/10.1021/acs.jafc.0c01475
  7. Computational and Experimental Assessments of Magnolol as a Neuroprotective Agent and Utilization of UiO-66(Zr) as Its Drug Delivery System vol.6, pp.38, 2012, https://doi.org/10.1021/acsomega.1c02555